Strand AI
Predict missing biological modalities from the data you already have.
Strand AI is an AI platform for life sciences teams that predicts missing multimodal patient data—such as gene expression, proteomics, and spatial transcriptomics—from routinely collected samples like H&E slides and genotypes. It helps clinical trial and biomarker discovery teams rescue incomplete cohorts, skip expensive assays, and surface predictive signatures without re-acquiring data. The platform targets a core challenge in oncology and rare disease research: the high cost and impracticality of measuring every biological modality for every patient.
Strand AI uses machine learning to predict missing biological modalities (e.g., proteomics, transcriptomics) from existing patient data such as H&E slides and genotype information.
Life sciences and biotech teams running clinical trials and biomarker discovery programs
Background.
- Status
- waitlist
- Business model
- unknown
- Company
- Strand AI
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.